This activity is expired and is no longer available for CME credit.


Personalized Medicine in Obesity Treatment: An In-depth Look at How to Use Today's Obesity Medications in Patients Who Need to Lose Weight

Author(s)/Faculty: Donna H. Ryan, MD, FACP; Robert F. Kushner, MD, MS, FACP; W. Timothy Garvey, MD; Timothy Church, MD, MPH, PhD
Release Date: 7/15/2014Expiration Date: 7/14/2015
Credit Type: CMENumber of Credits: 0
Content Type: MultimediaProvider:
Obesity has increased dramatically in the past 20 years, and is considered a health care epidemic in the United States. One-third of adults in the United States are considered obese, having a body mass index (BMI) ≥ 30 kg/m², according to the US Centers for Disease Control and Prevention. Serious health concerns associated with obesity include increased risk for hypertension, stroke, coronary heart disease, dyslipidemia, type 2 diabetes (T2DM), depression, sleep apnea, osteoarthritis, infertility, as well as cancers of the colon, breast, and endometrium. A BMI of ≥ 35 kg/m², high abdominal circumference, and waist-to-hip ratio are predictors of increased risk for mortality. Staying current with evidence-based recommendations for treatment, including knowledge of the safety and efficacy of emerging therapeutic options, is vital to healthcare practitioners as they work with patients to develop optimal, individualized, long-term strategies for overcoming obesity. This CME program features a case-based approach to address matching patient profiles to treatment options for obesity, communicating information to patients about weight loss and anti-obesity medications, and safety, efficacy, and the appropriate use of newly approved medications to treat obesity.